Respiratory Muscle Training in Adults With Spinal Cord Injury
Respiratory Muscle Training to Improve Functional Capacity and Prevent Respiratory Complications in Adults With Spinal Cord Injury
1 other identifier
interventional
112
1 country
1
Brief Summary
The purpose of this study is to investigate the effectiveness of a programme based on inspiratory and expiratory muscle training to improve respiratory muscle strength, functional capacity and avoid pulmonary complications in adults with cervical or high dorsal spinal cord injury (C5-D5) in acute phase.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 30, 2022
CompletedFirst Submitted
Initial submission to the registry
May 11, 2023
CompletedFirst Posted
Study publicly available on registry
June 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedJune 15, 2023
October 1, 2022
1.3 years
May 11, 2023
June 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in maximal expiratory pressure
The measurement of maximum static respiratory pressures will consist of performing maximum forced inspiration and expiration manoeuvres against an occluded airway in order to measure the pressure generated in the mouth, using a manometer or a pressure transducer, since, with the glottis open, the pressure in the mouth must be equal to the alveolar pressure.
Change after 6 weeks of intervention compared to baseline
Change in maximal inspiratory pressure
The measurement of maximum static respiratory pressures will consist of performing maximum forced inspiration and expiration manoeuvres against an occluded airway in order to measure the pressure generated in the mouth, using a manometer or a pressure transducer, since, with the glottis open, the pressure in the mouth must be equal to the alveolar pressure.
Change after 6 weeks of intervention compared to baseline
Secondary Outcomes (8)
Change in forced vital capacity (FVC)
Change after 6 weeks of intervention compared to baseline
Change in coughing capacity
Change after 6 weeks of intervention compared to baseline
Change in elbow flexion strength
Change after 6 weeks of intervention compared to baseline
Change in shoulder flexion strength
Change after 6 weeks of intervention compared to baseline
Change in number of people with respiratory complications
Change after 6 weeks of intervention compared to baseline
- +3 more secondary outcomes
Study Arms (2)
Respiratory muscle training
EXPERIMENTALRespiratory muscle training with the Orygen-Dual Valve (Forumed S.L. ESP) and an initial load of 30% of their maximum inspiratory and expiratory pressures.
Control group
SHAM COMPARATORSimulated training with the Orygen-Dual Valve (Forumed S.L. ESP), without load.
Interventions
The training of the intervention group will have an initial workload of 30% of maximal inspiratory and expiratory pressures, which will be increased weekly by 10% according to tolerance, if not tolerated by 5%. In addition, patients will be instructed to maintain a normal respiratory rate (12-16 breaths per minute). Moreover, they will continue their usual treatment.
In the control group, the respiratory muscle training will be simulated by using the device without load throughout the study period using an opaque adhesive tape surrounding the device to mask the valve position.
Eligibility Criteria
You may qualify if:
- People diagnosed with spinal cord injury.
- Over 18 years of age.
- Time of evolution less than 6 months and at least 4 weeks after the date of injury.
- Level of lesion between C5 and D5 and degree of involvement A or B. In case of involvement A with partial preservation zone this should not include abdominal musculature according to the international standardised classification of the American Spinal Injury Association.
You may not qualify if:
- People with chest trauma.
- Mechanically ventilated.
- Pregnant women.
- Any medical or psychiatric condition that could affect the ability to complete the study.
- Carrying a tracheostomy tube that does not tolerate occlusion.
- People who can not sit upright.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sara Reina Gutiérrez
Toledo, 45071, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ana Torres-Costoso
University of Castilla-La Mancha
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Masking of the researchers: randomisation of the sample will be performed using STATA software by a member of the research team who will not be involved in patient recruitment or data collection. The interventions will be carried out by researchers different from those who will perform the evaluation of the outcomes. Masking of the participants: the control group will have a training of the respiratory muscles simulated with the same device as the intervention group. They will use the device without load and with an opaque adhesive tape surrounding the device to mask the valve position.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2023
First Posted
June 15, 2023
Study Start
August 30, 2022
Primary Completion
December 30, 2023
Study Completion
December 30, 2023
Last Updated
June 15, 2023
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share
Only the research team, and the health authorities, who have a duty of confidentiality, will have access to all data collected by the study. Information that cannot be identified may be passed on to third parties.